Search Results 571-580 of 16956 for pharmacogenetics
The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Charles J. Bruce, M.B., Ch.B., a Mayo Clinic cardiologist, develops technologies that expand how cardiovascular care is delivered.
The study aims are to develop a consent-based IRB proposal that will enroll newborns who have imperforate anus. The proposal will include permission for ...
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
The Epigenetic Etiology of Human Disease Laboratory at Mayo Clinic is studying epigenetic mutations at the epigenome and transcriptome levels.
The primary purpose of this study is to identify which aspects of treatment are most prevalent and burdensome to patients with advanced heart failure.
The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...
Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in · Genetic testing provides insights to sudden unexplained ...
About this study. The purpose of this research study is to look at the advantages of using a 3D printed heart model for surgical planning in children who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.